Insulin aspart, recombinant Subcutaneous and Mechlorethamine Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mechlorethamine Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mechlorethamine
Brand name: Mustargen
Synonyms: Mechlorethamine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Meclicot
- Insulin aspart, recombinant Subcutaneous-Meclizine
- Insulin aspart, recombinant Subcutaneous-Meclizine Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Meclizine Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Meclizine Tablets
- Insulin aspart, recombinant Subcutaneous-Meclofenamate
- Mechlorethamine Intravenous-Insulin degludec
- Mechlorethamine Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Mechlorethamine Intravenous-Insulin Degludec (U-100) Vials
- Mechlorethamine Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Mechlorethamine Intravenous-Insulin degludec and liraglutide
- Mechlorethamine Intravenous-Insulin degludec and liraglutide Subcutaneous